PortfoliosLab logoPortfoliosLab logo
DNAVX vs. EGRAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

DNAVX vs. EGRAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dunham Dynamic Macro Fund (DNAVX) and Eaton Vance Global Macro Absolute Return Advantage Fund Class A (EGRAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DNAVX achieves a 3.29% return, which is significantly lower than EGRAX's 6.63% return. Over the past 10 years, DNAVX has underperformed EGRAX with an annualized return of 3.81%, while EGRAX has yielded a comparatively higher 6.26% annualized return.


DNAVX

1D
0.17%
1M
-0.85%
YTD
3.29%
6M
3.13%
1Y
4.55%
3Y*
7.97%
5Y*
4.34%
10Y*
3.81%

EGRAX

1D
0.16%
1M
0.91%
YTD
6.63%
6M
8.00%
1Y
19.57%
3Y*
13.29%
5Y*
8.35%
10Y*
6.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DNAVX vs. EGRAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DNAVX
Dunham Dynamic Macro Fund
3.29%5.12%6.13%18.70%-14.02%9.29%1.63%13.99%-8.44%8.09%
EGRAX
Eaton Vance Global Macro Absolute Return Advantage Fund Class A
6.63%20.06%9.19%8.10%-2.30%3.35%4.49%14.43%-8.66%5.49%

Correlation

The correlation between DNAVX and EGRAX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Sep 8, 2010

0.17

The correlation between DNAVX and EGRAX shifts across timeframes, from 0.09 (5 years) to 0.22 (3 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DNAVX vs. EGRAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DNAVX
DNAVX Risk / Return Rank: 2222
Overall Rank
DNAVX Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
DNAVX Sortino Ratio Rank: 1515
Sortino Ratio Rank
DNAVX Omega Ratio Rank: 1616
Omega Ratio Rank
DNAVX Calmar Ratio Rank: 3232
Calmar Ratio Rank
DNAVX Martin Ratio Rank: 3131
Martin Ratio Rank

EGRAX
EGRAX Risk / Return Rank: 9797
Overall Rank
EGRAX Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
EGRAX Sortino Ratio Rank: 9999
Sortino Ratio Rank
EGRAX Omega Ratio Rank: 9898
Omega Ratio Rank
EGRAX Calmar Ratio Rank: 9595
Calmar Ratio Rank
EGRAX Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DNAVX vs. EGRAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dunham Dynamic Macro Fund (DNAVX) and Eaton Vance Global Macro Absolute Return Advantage Fund Class A (EGRAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DNAVXEGRAXDifference
Sharpe ratioReturn per unit of total volatility

-4.37

Sortino ratioReturn per unit of downside risk

-6.28

Omega ratioGain probability vs. loss probability

1.21

2.49

-1.28

Calmar ratioReturn relative to maximum drawdown

2.14

5.84

-3.70

Martin ratioReturn relative to average drawdown

7.15

20.53

-13.38

DNAVX vs. EGRAX - Sharpe Ratio Comparison

The current DNAVX Sharpe Ratio is 1.13, which is lower than the EGRAX Sharpe Ratio of 5.50. The chart below compares the historical Sharpe Ratios of DNAVX and EGRAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


DNAVXEGRAXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.13

5.50

-4.37

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.51

2.09

-1.59

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

1.59

-1.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.34

1.24

-0.91

Drawdowns

DNAVX vs. EGRAX - Drawdown Comparison

The maximum DNAVX drawdown since its inception was -17.73%, which is greater than EGRAX's maximum drawdown of -14.15%. Use the drawdown chart below to compare losses from any high point for DNAVX and EGRAX.


Loading charts...

Drawdown Indicators


DNAVXEGRAXDifference

Max Drawdown

Largest peak-to-trough decline

-17.73%

-14.15%

-3.58%

Max Drawdown (1Y)

Largest decline over 1 year

-2.13%

-3.35%

+1.22%

Max Drawdown (3Y)

Largest decline over 3 years

-8.05%

-3.35%

-4.70%

Max Drawdown (5Y)

Largest decline over 5 years

-17.12%

-10.31%

-6.81%

Max Drawdown (10Y)

Largest decline over 10 years

-17.73%

-14.15%

-3.58%

Current Drawdown

Current decline from peak

-0.94%

-0.16%

-0.78%

Average Drawdown

Average peak-to-trough decline

-3.88%

-1.93%

-1.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.64%

0.95%

-0.31%

Volatility

DNAVX vs. EGRAX - Volatility Comparison

Dunham Dynamic Macro Fund (DNAVX) has a higher volatility of 1.39% compared to Eaton Vance Global Macro Absolute Return Advantage Fund Class A (EGRAX) at 0.87%. This indicates that DNAVX's price experiences larger fluctuations and is considered to be riskier than EGRAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DNAVXEGRAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

1.39%

0.87%

+0.52%

Volatility (6M)

Calculated over the trailing 6-month period

3.55%

3.18%

+0.37%

Volatility (1Y)

Calculated over the trailing 1-year period

4.05%

3.56%

+0.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

8.63%

4.01%

+4.62%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

8.42%

3.95%

+4.47%

DNAVX vs. EGRAX - Expense Ratio Comparison

DNAVX has a 1.88% expense ratio, which is lower than EGRAX's 2.22% expense ratio.


Dividends

DNAVX vs. EGRAX - Dividend Comparison

DNAVX's dividend yield for the trailing twelve months is around 11.19%, more than EGRAX's 6.34% yield.


PositionTTM20252024202320222021202020192018201720162015
DNAVX
Dunham Dynamic Macro Fund
11.19%11.56%0.00%3.41%0.00%0.00%0.75%0.00%2.42%0.00%0.00%0.00%
EGRAX
Eaton Vance Global Macro Absolute Return Advantage Fund Class A
6.34%6.76%5.86%3.18%4.53%4.58%5.61%4.02%0.00%2.82%1.47%6.42%

Frequently Asked Questions


DNAVX and EGRAX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DNAVX has higher volatility (1.39%) compared to EGRAX (0.87%). In terms of maximum drawdown, DNAVX dropped -17.73% vs EGRAX's -14.15%.

EGRAX currently has the higher Sharpe Ratio (5.50 vs 1.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DNAVX and EGRAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer